Therapeutics: First STAT forward.
- Published in:
- Nature Reviews Cancer, 2012, v. 12, n. 8, p. 511, doi. 10.1038/nrc3335
- By:
- Publication type:
- Article
Works matching IS 1474175X AND DT 2012 AND VI 12 AND IP 8
Results: 22
1
2
Kinesins and cancer.
- Published in:
- Nature Reviews Cancer, 2012, v. 12, n. 8, p. 527, doi. 10.1038/nrc3310
- By:
- Publication type:
- Article
3
Mechanotransduction: Catching the X-waves.
- Published in:
- Nature Reviews Cancer, 2012, v. 12, n. 8, p. 510, doi. 10.1038/nrc3331
- By:
- Publication type:
- Article
4
From cancer genomes to oncogenic drivers, tumour dependencies and therapeutic targets.
- Published in:
- Nature Reviews Cancer, 2012, v. 12, n. 8, p. 572, doi. 10.1038/nrc3299
- By:
- Publication type:
- Article
5
Field effect.
- Published in:
- 2012
- By:
- Publication type:
- journal article
6
The ERBB network: at last, cancer therapy meets systems biology.
- Published in:
- Nature Reviews Cancer, 2012, v. 12, n. 8, p. 553, doi. 10.1038/nrc3309
- By:
- Publication type:
- Article
7
Tumour evolution: Mutable markers.
- Published in:
- Nature Reviews Cancer, 2012, v. 12, n. 8, p. 511, doi. 10.1038/nrc3338
- By:
- Publication type:
- Article
8
Towards a mechanism.
- Published in:
- 2012
- By:
- Publication type:
- journal article
9
The rationale for targeting the LOX family in cancer.
- Published in:
- Nature Reviews Cancer, 2012, v. 12, n. 8, p. 540, doi. 10.1038/nrc3319
- By:
- Publication type:
- Article
10
NRF2 and cancer: the good, the bad and the importance of context.
- Published in:
- Nature Reviews Cancer, 2012, v. 12, n. 8, p. 564, doi. 10.1038/nrc3278
- By:
- Publication type:
- Article
11
Developmental reprogramming of cancer susceptibility.
- Published in:
- Nature Reviews Cancer, 2012, v. 12, n. 8, p. 578, doi. 10.1038/nrc3334
- By:
- Publication type:
- Article
12
Antitumour potential of catalytic DNA.
- Published in:
- 2012
- By:
- Publication type:
- journal article
13
Domino effect.
- Published in:
- 2012
- By:
- Publication type:
- journal article
14
Pushing the limits of targeted therapy in chronic myeloid leukaemia.
- Published in:
- Nature Reviews Cancer, 2012, v. 12, n. 8, p. 513, doi. 10.1038/nrc3317
- By:
- Publication type:
- Article
15
Suppressing the rejection of pancreatic tumours.
- Published in:
- 2012
- By:
- Publication type:
- journal article
16
Genes, genes everywhere...
- Published in:
- 2012
- By:
- Publication type:
- journal article
17
The haves and the have nots.
- Published in:
- 2012
- By:
- Publication type:
- journal article
18
Upper urinary tract urothelial cancers: where it is A:T.
- Published in:
- Nature Reviews Cancer, 2012, v. 12, n. 8, p. 503, doi. 10.1038/nrc3311
- By:
- Publication type:
- Article
19
The great pretenders.
- Published in:
- 2012
- By:
- Publication type:
- journal article
20
Genomic instability: Divide and conquer.
- Published in:
- Nature Reviews Cancer, 2012, v. 12, n. 8, p. 511, doi. 10.1038/nrc3336
- By:
- Publication type:
- Article
21
At the hypusine of the crime.
- Published in:
- 2012
- By:
- Publication type:
- journal article
22
Therapeutics: Therapy targets ribosomal reliance.
- Published in:
- Nature Reviews Cancer, 2012, v. 12, n. 8, p. 511, doi. 10.1038/nrc3337
- By:
- Publication type:
- Article